Search – Page 144 – Indianapolis Business Journal

Home » Search

Articles

Holcomb taking global approach to economic development

October 21, 2017

The governor helped persuade India-based outsourcing firm Infosys to establish offices in Indianapolis, got skeptical GOP lawmakers to fund a direct flight between Indianapolis and Paris, and signed an agreement to deepen economic ties with Japan.

Lilly plans $72M upgrade for Indianapolis insulin operation

October 23, 2017

The Indianapolis drugmaker said it will use the money to replace an existing line that fills vials for Humalog and Humulin and to prepare for new insulin products.

Lilly takes big bet on German startup’s cancer technology

October 23, 2017

The Indianapolis-based drugmaker is collaborating with CureVac AG to develop up to five cancer products. The products will be based on a new field of biotechnology sweeping the industry.

Lilly considers sale, spinoff of Elanco animal-health business

October 24, 2017

The company announced Tuesday that it is reviewing options for the Greenfield-based division, "including an initial public offering, merger, sale, or retention of the business."

Lilly shares slide on news of possible sale, spinoff of Elanco

October 24, 2017

Despite slipping sales and lost market share, the Elanco animal-health unit is strong and the time is right to explore selling or spinning it off, Eli Lilly and Co. officials said Tuesday.

2017 WOMAN OF INFLUENCE: Melissa Stapleton Barnes

October 27, 2017

At Eli Lilly and Co., Melissa Stapleton Barnes leads an organization responsible for ethics and compliance in nearly 90 countries around the world.

2017 WOMAN OF INFLUENCE: Joyce Irwin

October 27, 2017

Joyce Irwin directs the Community Health Network Foundation, which is dedicated to serving the needs of both patients and caregivers with funding for programs such as an Oncology Assistance Fund.

2017 WOMAN OF INFLUENCE: Yolanda Johnson-Moton

October 27, 2017

Since joining Eli Lilly and Co., Yolanda Johnson-Moton has launched education and engagement platforms, including the Lilly for Better Health website, and brought the company to YouTube via Lilly Health Channel.

Tobias gift of $5M to establish IU global development center

October 31, 2017

Indiana University will create a research laboratory focused on international development—including missions such as reducing poverty and inequality and addressing climate change—based on a $5 million gift from Deborah and Randall Tobias.

Assessing Elanco options: sale, spinoff or status quo?

November 2, 2017

Lilly CEO David Ricks says the time is right “to consider a variety of options to maximize future value,” such as an initial public offering. But analysts say an IPO would make more sense if Elanco were performing better.

More than 2,300 Lilly workers volunteer for buyouts

November 6, 2017

The buyouts set the stage for a huge departure of workers by December 31, the largest reduction since Lilly cut 5,500 workers nearly a decade ago.

Trump expected to name ex-Lilly exec to lead Health & Human Services

November 9, 2017

Alex Azar, who ran U.S. operations for Eli Lilly before leaving in January, would be the administration’s point person on running—or dismantling—Obamacare.

Bring offshore profits home—but companies shouldn’t squander cash

November 9, 2017

There is an estimated $2.6 trillion in profits that companies have made in other parts of the world—and are leaving there to avoid paying hefty taxes on the earnings when they transfer the money to the United States.

Trump names former Lilly exec as new health secretary

November 13, 2017

If confirmed by the Senate, former Eli Lilly and Co. exec Alex Azar will oversee a $1 trillion department responsible for major health insurance programs, medical research, food and drug safety, and public health.

Phoenix hires co-leader to manage new theater

November 16, 2017

New Managing Director Kevin Kruse is the first to answer directly to the board, instead of to Artistic Director Bryan Fonseca.

Trump’s HHS nominee reaped big earnings from drug industry tenure

November 20, 2017

As a top pharma industry veteran from 2007 to 2017, former Eli Lilly and Co. executive Alex Azar built a substantial financial portfolio now worth as much as $20.6 million.

Indy biopharma startup raises another $20M, shifts focus

November 20, 2017

The company is riding a roller coaster since its launch only 20 months ago, raising a total of $61 million, but abruptly changing gears on drug candidates.

Tangled incentives push drugmakers away from opioid solutions

November 25, 2017

Pharmaceutical companies have introduced medicines to treat dependence, reverse overdoses and deal with opioid side effects. But few effective and economically viable alternatives to addictive painkillers have emerged from the laboratory.

In Trump health secretary pick, Dems have questions but hope

November 28, 2017

As Alex Azar faces his first nomination hearing, even some critics see signs he could shift the health care debate away from partisan confrontation.

Senators of both parties quiz Trump health pick on drug costs

November 29, 2017

Members of the Senate Health, Education, Labor and Pensions Committee asked Alex Azar, a former executive for Indianapolis-based Eli Lilly and Co., if he would put the public first if he is confirmed as secretary of the Department of Health and Human Services.

« Previous 1 … 142 143 144 145 146 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Holcomb taking global approach to economic development

Lilly plans $72M upgrade for Indianapolis insulin operation

Lilly takes big bet on German startup’s cancer technology

Lilly considers sale, spinoff of Elanco animal-health business

2017 WOMAN OF INFLUENCE: Melissa Stapleton Barnes

2017 WOMAN OF INFLUENCE: Joyce Irwin

2017 WOMAN OF INFLUENCE: Yolanda Johnson-Moton

Tobias gift of $5M to establish IU global development center

Assessing Elanco options: sale, spinoff or status quo?

More than 2,300 Lilly workers volunteer for buyouts

Trump expected to name ex-Lilly exec to lead Health & Human Services

Bring offshore profits home—but companies shouldn’t squander cash

Trump names former Lilly exec as new health secretary

Phoenix hires co-leader to manage new theater

Trump’s HHS nominee reaped big earnings from drug industry tenure

Indy biopharma startup raises another $20M, shifts focus

Tangled incentives push drugmakers away from opioid solutions

In Trump health secretary pick, Dems have questions but hope

Senators of both parties quiz Trump health pick on drug costs